FormulaFolio Investments’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$5K Hold
30
﹤0.01% 342
2021
Q1
$4K Sell
30
-4,032
-99% -$640K ﹤0.01% 355
2020
Q4
$615K Buy
+4,062
New +$581K 0.01% 413
2020
Q1
Sell
-4,829
Closed -$582K 326
2019
Q4
$582K Buy
4,829
+97
+2% +$10.8K 0.02% 226
2019
Q3
$471K Buy
4,732
+186
+4% +$19.5K 0.02% 233
2019
Q2
$496K Buy
4,546
+1,166
+34% +$124K 0.02% 206
2019
Q1
$378K Buy
+3,380
New +$371K 0.02% 232

Other funds holding IBB

FormulaFolio Investments's IBB Position: Q2 2021 in Review

FormulaFolio Investments held its iShares Biotechnology ETF (IBB) position steady in Q2 2021 at 30 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #342.

FormulaFolio Investments first reported a position in IBB in Q1 2019 and has held it in 7 quarters since. The position peaked at $615K in Q4 2020. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

  • FormulaFolio Investments held 30 shares of iShares Biotechnology ETF worth $5K as of Q2 2021.
  • FormulaFolio Investments left its iShares Biotechnology ETF share count unchanged in Q2 2021.
  • iShares Biotechnology ETF made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #342 holding.
  • FormulaFolio Investments first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 7 quarters since.
  • FormulaFolio Investments's iShares Biotechnology ETF position peaked at $615K in Q4 2020.
  • 863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.